<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Morfill C</submitter><funding>Cancer Research UK</funding><funding>FP7 People: Marie-Curie Actions</funding><funding>Medical Research Council</funding><funding>Imperial College London</funding><funding>Royal Society of Chemistry</funding><funding>Wellcome Trust</funding><funding>Division of Intramural Research, National Institute of Allergy and Infectious Diseases</funding><funding>Engineering and Physical Sciences Research Council</funding><funding>Michael J. Fox Foundation for Parkinson&amp;apos;s Research</funding><pagination>47445-47460</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9614720</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(42)</volume><pubmed_abstract>A challenge in neurology is the lack of efficient brain-penetrable neuroprotectants targeting multiple disease mechanisms. Plasmonic gold nanostars are promising candidates to deliver standard-of-care drugs inside the brain but have not been trialed as carriers for neuroprotectants. Here, we conjugated custom-made peptide dendrimers (termed H3/H6), encompassing motifs of the neurotrophic S100A4-protein, onto star-shaped and spherical gold nanostructures (H3/H6-AuNS/AuNP) and evaluated their potential as neuroprotectants and interaction with neurons. The H3/H6 nanostructures crossed a model blood-brain barrier, bound to plasma membranes, and induced neuritogenesis with the AuNS, showing higher potency/efficacy than the AuNP. The H3-AuNS/NP protected neurons against oxidative stress, the H3-</pubmed_abstract><journal>ACS applied materials &amp; interfaces</journal><pubmed_title>Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders.</pubmed_title><pmcid>PMC9614720</pmcid><funding_grant_id>11713</funding_grant_id><funding_grant_id>EP/L015277/1</funding_grant_id><funding_grant_id>R01AI145436</funding_grant_id><funding_grant_id>P627049</funding_grant_id><funding_grant_id>FC0010218</funding_grant_id><pubmed_authors>Kiryushko D</pubmed_authors><pubmed_authors>Fernando NK</pubmed_authors><pubmed_authors>Pinna A</pubmed_authors><pubmed_authors>Pankratova S</pubmed_authors><pubmed_authors>Klosowski M</pubmed_authors><pubmed_authors>Wilkinson RJ</pubmed_authors><pubmed_authors>Machado P</pubmed_authors><pubmed_authors>Talamona F</pubmed_authors><pubmed_authors>Morfill C</pubmed_authors><pubmed_authors>Xie F</pubmed_authors><pubmed_authors>Regoutz A</pubmed_authors><pubmed_authors>Porter AE</pubmed_authors><pubmed_authors>Fleck RA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders.</name><description>A challenge in neurology is the lack of efficient brain-penetrable neuroprotectants targeting multiple disease mechanisms. Plasmonic gold nanostars are promising candidates to deliver standard-of-care drugs inside the brain but have not been trialed as carriers for neuroprotectants. Here, we conjugated custom-made peptide dendrimers (termed H3/H6), encompassing motifs of the neurotrophic S100A4-protein, onto star-shaped and spherical gold nanostructures (H3/H6-AuNS/AuNP) and evaluated their potential as neuroprotectants and interaction with neurons. The H3/H6 nanostructures crossed a model blood-brain barrier, bound to plasma membranes, and induced neuritogenesis with the AuNS, showing higher potency/efficacy than the AuNP. The H3-AuNS/NP protected neurons against oxidative stress, the H3-</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-04T09:42:22.966Z</modification><creation>2025-04-04T09:42:22.966Z</creation></dates><accession>S-EPMC9614720</accession><cross_references><pubmed>36218307</pubmed><doi>10.1021/acsami.2c14220</doi></cross_references></HashMap>